Development of a Metabolomics Platform for in vivo Assessment of Impacts of Xenobiotics on the CNS
Research output: Chapters, Conference Papers, Creative and Literary Works › RGC 32 - Refereed conference paper (with host publication) › peer-review
Author(s)
Detail(s)
| Original language | English |
|---|---|
| Title of host publication | PROCEEDINGS OF THE II INTERNATIONAL CONFERENCE ON ENVIRONMENTAL STRESSORS IN BIOLOGY AND MEDICINE INTERNATIONAL CONGRESS ON PERSONALIZED MEDICINE 4TH ASIAN PACIFIC CONGRESS ON BRONCHOLOGY AND INTERVENTIONAL PULMONOLOGY |
| Publisher | MEDIMOND S R L |
| Pages | 51-53 |
| Number of pages | 3 |
| ISBN (print) | 978-88-7587-643-2 |
| Publication status | Published - 2012 |
Conference
| Title | International Congress on Personalized Medicine (UPCP) |
|---|---|
| Place | Italy |
| City | Florence |
| Period | 2 - 5 February 2012 |
Link(s)
| Permanent Link | https://scholars.cityu.edu.hk/en/publications/publication(8d31cdf0-619e-46fe-9fc4-e35882099437).html |
|---|
Abstract
Since metabolites are the downstream products of gene expression, such a metabolomics platform would provide an instantaneous snapshot of biochemical abundances, and form a more popular tool for the identification of useful biomarkers of disease and exposure to xenobiotics; and for the elucidation of biological pathways / molecular mechanisms of pharmacological effect and toxicity. In our studies, we have developed a metabolomics platform on neurotransmitters in Oryzias melastigma to study complex diseases and effects of xenobiotics on the neuropathways of the central nervous system (CNS) in vertebrates.
Citation Format(s)
PROCEEDINGS OF THE II INTERNATIONAL CONFERENCE ON ENVIRONMENTAL STRESSORS IN BIOLOGY AND MEDICINE INTERNATIONAL CONGRESS ON PERSONALIZED MEDICINE 4TH ASIAN PACIFIC CONGRESS ON BRONCHOLOGY AND INTERVENTIONAL PULMONOLOGY. MEDIMOND S R L, 2012. p. 51-53.
Research output: Chapters, Conference Papers, Creative and Literary Works › RGC 32 - Refereed conference paper (with host publication) › peer-review
